Bank Of Montreal Alkermes Plc. Transaction History

Bank Of Montreal

$197 Billion
Q2 2024

A detailed history of Bank Of Montreal transactions in Alkermes Plc. stock. As of the latest transaction made, Bank Of Montreal holds 47,756 shares of ALKS stock, worth $1.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

47,756

Previous 22,594 111.37%

Holding current value

$1.4 Million

Previous $611,000 88.22%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$23.21 - $27.24 $584,010 - $685,412	25,162 Added 111.37%	47,756 $1.15 Million
Q1 2024 May 13, 2024	SELL	$26.4 - $32.56 $274,903 - $339,047	-10,413 Reduced 31.55%	22,594 $611,000
Q4 2023 Feb 08, 2024	BUY	$23.37 - $28.68 $386,095 - $473,822	16,521 Added 100.21%	33,007 $915,000
Q3 2023 Nov 01, 2023	BUY	$27.17 - $31.97 $79,445 - $93,480	2,924 Added 21.56%	16,486 $461,000
Q2 2023 Aug 02, 2023	BUY	$28.34 - $33.63 $147,311 - $174,808	5,198 Added 62.15%	13,562 $424,000
Q1 2023 Jun 13, 2024	SELL	$25.31 - $29.02 $135,940 - $155,866	-5,371 Reduced 23.77%	17,223 $485,000
Q4 2022 Feb 01, 2023	BUY	$21.94 - $26.24 $9,148 - $10,942	417 Added 5.25%	8,364 $218,000
Q3 2022 Nov 10, 2022	SELL	$22.0 - $31.87 $660 - $956	-30 Reduced 0.38%	7,947 $190,000
Q2 2022 Aug 11, 2022	BUY	$26.4 - $30.54 $9,451 - $10,933	358 Added 4.7%	7,977 $243,000
Q1 2022 May 12, 2022	BUY	$23.07 - $27.99 $175,770 - $213,255	7,619 New	7,619 $203,000
Q4 2021 Feb 11, 2022	SELL	$21.47 - $32.08 $8.18 Million - $12.2 Million	-381,213 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$23.37 - $32.13 $352,115 - $484,102	-15,067 Reduced 3.8%	381,213 $12.3 Million
Q2 2021 Aug 12, 2021	BUY	$18.78 - $25.15 $7.44 Million - $9.97 Million	396,280 New	396,280 $9.64 Million

Others Institutions Holding ALKS

# of Institutions

349

Shares Held

183M

Call Options Held

209K

Put Options Held

89.4K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.81B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account